Sale price marks roughly a 47% decline from the biotech firm’s purchase 5 years ago The commercial real estate market in California's biotech corridor is testing investor appetite for vacant buildings, as pharmaceutical giant Amgen Inc. prepares to sell a nearly 100,000-square-foot property in Thousand Oaks at roughly half what it paid six years ago. […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Mizrahi Tefahot Bank’s U.S. operation, a Downtown Los Angeles fixture for more...
ByThe RegistryOctober 7, 2026Consulting firm ICF is moving its Los Angeles office roughly a block...
ByThe RegistryOctober 7, 2026Regent Properties has asked Los Angeles to bend 13 development standards so...
ByThe RegistryOctober 6, 2026State Farm has renewed 46,312 square feet at Glendale Plaza, 655 N...
ByThe RegistryOctober 5, 2026Error: Contact form not found.